Literature DB >> 9674477

Pulmonary aspergillosis and invasive disease in AIDS: review of 342 cases.

E Mylonakis1, T F Barlam, T Flanigan, J D Rich.   

Abstract

Aspergillosis is an infrequent but commonly fatal infection among HIV-infected individuals. We review 342 cases of pulmonary Aspergillus infection that have been reported among HIV-infected patients, with a focus on invasive disease. Invasive pulmonary aspergillosis usually occurs among patients with <50 CD4 cells/mm3. Major predisposing conditions include neutropenia and steroid treatment. Fever, cough, and dyspnea are each present in >60% of the cases. BAL is often suggestive, but biopsy specimens are necessary for definite diagnosis. Amphotericin B is the mainstay of treatment and mortality is > 80%. Avoiding neutropenia and judicious use of steroids may be helpful in prevention. Aggressive diagnostic approach, early initiation of treatment, adequate dosing of antifungals, and close follow-up may improve the currently dismal prognosis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9674477     DOI: 10.1378/chest.114.1.251

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  25 in total

Review 1.  [The radiology of opportunistic pneumonias. I: Epidemiological, laboratory and clinical background].

Authors:  S Tuengerthal
Journal:  Radiologe       Date:  2005-04       Impact factor: 0.635

2.  The pathogenesis of fatal outcome in murine pulmonary aspergillosis depends on the neutrophil depletion strategy.

Authors:  Shane D Stephens-Romero; Aron J Mednick; Marta Feldmesser
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

Review 3.  Management of patients with HIV in the intensive care unit.

Authors:  Henry Masur
Journal:  Proc Am Thorac Soc       Date:  2006

Review 4.  Cavitary pulmonary disease.

Authors:  L Beth Gadkowski; Jason E Stout
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

5.  Endogenous Aspergillus versicolor endophthalmitis in an immuno-competent HIV-positive patient.

Authors:  Paolo Perri; Claudio Campa; Carlo Incorvaia; Francesco Parmeggiani; Giuseppe Lamberti; Ciro Costagliola; Adolfo Sebastiani
Journal:  Mycopathologia       Date:  2005-10       Impact factor: 2.574

Review 6.  Hospital epidemiology and infection control in acute-care settings.

Authors:  Emily R M Sydnor; Trish M Perl
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

7.  Mycological Profile of Sputum of HIV Positive Patients with Lower Respiratory Tract Infection and its Correlation with CD4+ T Lymphocyte Count.

Authors:  Jyotsna Chandwani; Nitya Vyas; Saroj Hooja; Babita Sharma; Rakesh Maheshwari
Journal:  J Clin Diagn Res       Date:  2016-09-01

Review 8.  Antifungal drug discovery through the study of invertebrate model hosts.

Authors:  R Pukkila-Worley; E Holson; F Wagner; E Mylonakis
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

Review 9.  Other HIV-associated pneumonias.

Authors:  Jakrapun Pupaibool; Andrew H Limper
Journal:  Clin Chest Med       Date:  2013-04-08       Impact factor: 2.878

10.  Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.

Authors:  Thomas F Patterson; George R Thompson; David W Denning; Jay A Fishman; Susan Hadley; Raoul Herbrecht; Dimitrios P Kontoyiannis; Kieren A Marr; Vicki A Morrison; M Hong Nguyen; Brahm H Segal; William J Steinbach; David A Stevens; Thomas J Walsh; John R Wingard; Jo-Anne H Young; John E Bennett
Journal:  Clin Infect Dis       Date:  2016-06-29       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.